Initial Public Offering |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Initial Public Offering | |||||||||||||||||||||||||||||||||||||||||||||||||||
Initial Public Offering | Note 3 – Initial Public Offering
On April 5, 2022, the Company sold 115,000,000 related to the IPO. Each Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an Initial Business Combination. Each one redeemable warrants entitle the holder thereof to purchase one ordinary share, and each ten rights entitle the holder thereof to receive one ordinary share at the closing of a Business Combination. No fractional shares issued upon separation of the Units, and only whole Warrants will trade. Units (including the issuance of 1,500,000 Units as a result of the underwriter’s fully exercise of the over-allotment) at a price of $ per Unit, generating gross proceeds of $
The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 15,000,000 (see Note 7). Public Units to cover over-allotments. On April 5, 2022, the underwriter exercised the over-allotment option in full to purchase 1,500,000 Public Units, at a purchase price of $ per Public Unit, generating gross proceeds to the Company of $
At December 31, 2022, the ordinary share reflect in the balance sheet are reconciled in the following tables:
|